17-4782605-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_003963.3(TM4SF5):āc.361A>Gā(p.Asn121Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000206 in 1,613,944 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_003963.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TM4SF5 | NM_003963.3 | c.361A>G | p.Asn121Asp | missense_variant | 3/5 | ENST00000270560.4 | NP_003954.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TM4SF5 | ENST00000270560.4 | c.361A>G | p.Asn121Asp | missense_variant | 3/5 | 1 | NM_003963.3 | ENSP00000270560 | P1 | |
TM4SF5 | ENST00000576530.2 | n.400A>G | non_coding_transcript_exon_variant | 3/4 | 1 |
Frequencies
GnomAD3 genomes AF: 0.000724 AC: 110AN: 151968Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000290 AC: 73AN: 251448Hom.: 0 AF XY: 0.000184 AC XY: 25AN XY: 135896
GnomAD4 exome AF: 0.000152 AC: 222AN: 1461858Hom.: 0 Cov.: 32 AF XY: 0.000157 AC XY: 114AN XY: 727232
GnomAD4 genome AF: 0.000723 AC: 110AN: 152086Hom.: 0 Cov.: 32 AF XY: 0.000726 AC XY: 54AN XY: 74340
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 02, 2021 | The c.361A>G (p.N121D) alteration is located in exon 3 (coding exon 3) of the TM4SF5 gene. This alteration results from a A to G substitution at nucleotide position 361, causing the asparagine (N) at amino acid position 121 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at